Eguac, Rosalie A.
HRN: 26-54-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/10/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/10/2025
03/17/2025
IV
300mg
Q8
NON-HEALING WOUND
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes